I don't think anyone has been able to travel to Japan and vice versa so this is a promising development. There'll be many more.
No matter how good your product or technology is it takes time to establish relationships and prove up your worth.
This company is doing everything right.
Once it becomes easier for execs. to travel opportunities will turn into outcomes.
- Forums
- ASX - By Stock
- TYP
- Ann: Exopharm LEAP Technology - Second Commercial Collaboration
Ann: Exopharm LEAP Technology - Second Commercial Collaboration, page-7
Featured News
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.10M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.6¢ | $297.0K | 6.063M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 249224 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 0.048 |
1 | 260000 | 0.047 |
1 | 54347 | 0.046 |
5 | 1069599 | 0.045 |
2 | 300000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 249224 | 2 |
0.050 | 158497 | 2 |
0.053 | 200759 | 2 |
0.054 | 285561 | 4 |
0.055 | 192266 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online